2020 European guideline on the management of syphilis.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
12
06
2020
accepted:
04
09
2020
pubmed:
24
10
2020
medline:
15
5
2021
entrez:
23
10
2020
Statut:
ppublish
Résumé
The 2020 edition of the European guideline on the management of syphilis is an update of the 2014 edition. Main modifications and updates include: -The ongoing epidemics of early syphilis in Europe, particularly in men who have sex with men (MSM) -The development of dual treponemal and non-treponemal point-of-care (POC) tests -The progress in non-treponemal test (NTT) automatization -The regular episodic shortage of benzathine penicillin G (BPG) in some European countries -The exclusion of azithromycin as an alternative treatment at any stage of syphilis -The pre-exposure or immediate post-exposure prophylaxis with doxycycline in populations at high risk of acquiring syphilis.
Substances chimiques
Anti-Bacterial Agents
0
Penicillin G Benzathine
RIT82F58GK
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
574-588Informations de copyright
© 2020 European Academy of Dermatology and Venereology.
Références
European Centre for Disease Prevention and Control. http://www.ecdc.europa.eu/.
World Health Organization. WHO guidelines for the treatment of Treponema pallidum (syphilis) 2016 http://www.who.int/reproductivehealth/publications/rtis/syphilis-treatment-guidelines/en.
Spiteri G, Unemo M, Mårdh O, Amato-Gauci AJ. The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe. Epidemiol Infect 2019; 147: e143. https://doi.org/10.1017/S0950268819000281.
Janier M, Hegyi V, Dupin N, Unemo M, Tiplica GS, French P et al. 2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol 2014; 20: 300-309.
Grassly NC, Fraser C, Garnett GP. Host immunity and synchronized epidemics of syphilis across the United Stades. Nature 2005; 433: 417-421.
Centers for Diseases Control and Prevention. Syphilis (Treponema pallidum) 2018. Case definition. CSTE 17-ID-11.
Hook EW, 3rd. Syphilis. Lancet 2017; 389: 1550-1557.
Dupin N. Syphilis. Rev Med Interne 2016; 37: 735-742.
Peeling RW, Mabey D, Kamb ML, Chen XS, Radolf JD, Benzaken AS. Syphilis. Nat Rev Dis Primers 2017; 3: 17073. https://doi.org/10.1038/nrdp.2017.73.
Kovacs CS, Jr, Koval CE, van Duin D et al. Selecting suitable solid organ transplant donors: reducing the risk of donor-transmitted infections. World J Transplant 2014; 4: 43-56.
Rompalo AM, Lawlor J, Seaman P, Quinn TC, Zenilman JM, Hook EW. Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis 2001; 28: 448-454.
Hope-Rapp E, Anyfantakis V, Fouéré S et al. Etiology of genital ulcer disease. A prospective study of 278 cases seen in an STD clinic in Paris. Sex Transm Dis 2010; 37: 153-158.
Towns JM, Leslie DE, Denham J, Azzato F, Fairley CK, Chen M. Painful and multiple anogenital lesions are common in men with Treponema pallidum PCR-positive primary syphilis without Herpes simplex virus coinfection: a cross-sectional clinic-based study. Sex Transm Infect 2016; 92: 112-115.
Farhi D, Benhaddou N, Grange P et al. Clinical and serologic baseline and follow up features of syphilis according to HIV status in the post HAART era. Medicine 2009; 88: 331-340.
Vanhaecke C, Grange P, Benhaddou N et al. Clinical and biological characteristics of 40 patients with neurosyphilis and evaluation of Treponema pallidum nested polymerase chain reaction in cerebrospinal fluid samples. Clin Infect Dis 2016; 63: 1180-1188.
Dombrowski JC, Pedersen R, Marra CM, Kerani R, Golden MR. Prevalence estimates of complicated syphilis. Sex Transm Dis 2015; 42: 702-704.
Park KH, Lee MS, Hong IK et al. Bone involvement in secondary syphilis: a case report and systematic review of the literature. Sex Transm Dis 2014; 41: 532-537.
Mishra S, Walmsley SL, Loutfy MR, Kaul R, Logue KJ, Gold WL. Otosyphilis in HIV-coinfected individuals: a case series from Toronto, Canada. AIDS Patient Care STDS 2008; 22: 213-219.
Davey DJ, Kojima N, Konda KA et al. Transient aortitis documented by positron emission tomography in a case series of men and transgender women infected with syphilis. Sex Transm Infect 2017; 93: 551-555.
MMWR: CDC case definitions for public health surveillance. Oct 19 1990/vol.39/No.RR-13.
Wheeler HL, Agarwal S, Goh BT. Dark ground microscopy and treponemal serological tests in the diagnosis of early syphilis. Sex Transm Infect 2004; 80: 411-414.
Ballard R, Hook EW, III. Syphilis. In: Unemo M, Ballard R, Ison C, Lewis D, Ndowa F, Peeling R, eds. Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. Geneva: World Health Organization (WHO). 2013; 107-129.
Grange PA, Gressier L, Dion PL et al. Evaluation of a PCR test for detection of Treponema pallidum in swabs and blood. J Clin Microbiol 2012; 50: 546-552.
Marks M, Lawrence D, Kositz C, Mabey D. Diagnostic performance of PCR assays for the diagnosis of neurosyphilis: a systematic review. Sex Transm Infect 2018; 94: 585-588.
Gayet-Ageron A, Sednaoui P, Lautenschlager S, et al. Use of Treponema pallidum PCR in testing of ulcers for diagnosis of primary syphilis. Emerg Infect Dis 2015; 21: 127-129.
Shields M, Guy RJ, Jeoffreys NJ, Finlayson RJ, Donovan B. A longitudinal evaluation of Treponema pallidum PCR testing in early syphilis. BMC Infect Dis 2012; 12: 353. https://doi.org/10.1186/1471-2334-12-353.
Buffet M, Grange PA, Gerhardt P et al. Diagnosing Treponema pallidum in secondary syphilis by PCR and immunohistochemistry. J Invest Dermatol 2007; 127: 2345-2350.
Müller H, Eisendle K, Bräuninger W, Kutzner H, Cerroni L, Zelger B. Comparative analysis of immuno-histochemistry, polymerase chain reaction and focus-floating microscopy for the detection of Treponema pallidum in mucocutaneous lesions of primary, secondary and tertiary syphilis. Br J Dermatol 2011; 165: 50-60.
Petrich A, Rojas P, Schulze J et al. Fluorescence in situ hybridization for the identification of Treponema pallidum in tissue sections. Int J Med Microbiol 2015; 305: 709-718.
Grange PA, Allix-Beguec C, Chanal J et al. Molecular subtyping of Treponema pallidum in Paris, France. Sex Transm Dis 2013; 40: 641-644.
Peng RR, Wang AL, Li J, Tucker JD, Yin YP, Chen XS. Molecular typing of Treponema pallidum: a systematic review and meta-analysis. PLoS Negl Trop Dis 2011; 5: e1273.
Ho EL, Lukehart SA. Syphilis: using modern approaches to understand an old disease. J Clin Invest 2011; 121: 4584-4592.
Popisilova P, Grange PA, Grillova L et al. Multi-locus sequence typing of Treponema pallidum subsp. pallidum present in clinical samples from France: infecting treponemes are genetically diverse and belong to 18 allelic profiles. PLoS One 2018; 13: e0201068. https://doi.org/10.1371/journal.pone.0201068.
Beale MA, Marks M, Sahi SK et al. Genomic epidemiology of syphilis reveals independent emergence of macrolide resistance across multiple circulating lineages. Nat Commun 2019; 10: 3255-3263.
Vrbova E, Grillov L, Mikalova L et al. MLST typing of Treponema pallidum subsp. pallidum in the Czech Republic during 2004-2017: Clinical isolates belonged to 25 allelic profiles and harboured 8 novel allelic variants. PLoS One 2019; 14: e0217611.
Grillova L, Jolley K, Smajs D, Picardeau M. A public data base for the new MLST scheme for Treponema pallidum subsp. pallidum: surveillance and epidemiology of the causative agent of syphilis. Peer J 2019; 6: e6182.
Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995; 8: 1-21.
Nandwani R, Evans DTP. Are you sure it’s syphilis? A review of false positive serology. Int J STD AIDS 1995; 6: 241-248.
Young H. Guidelines for serological testing for syphilis. Sex Transm Infect 2000; 76: 403-405.
Hunter M, Robertson PW, Post JJ. Significance of isolated reactive treponemal chemiluminescence immunoassay results. J Infect Dis 2013; 207: 1416-1423.
Cole MJ, Perry KR, Parry JV. Comparative evaluation of 15 serological assays for the detection of syphilis infection. Eur J Clin Microbiol Infect Dis 2007; 26: 705-713.
Binnicker MJ, Jespersen DJ, Rollins LO. Treponema-specific tests for serodiagnosis of syphilis: comparative evaluation of seven assays. J Clin Microbiol 2011; 49: 1313-1317.
Gratzer B, Pohl D, Hotton AL et al. Evaluation of diagnostic serological results in cases of suspected primary syphilis infection. Sex Transm Dis 2014; 41: 285-289.
Busse C, Navid MH, Strubel A, Schnitzler P. Evaluation of a new recombinant antigen-based Virotech Treponema pallidum screen ELISA for diagnosis of syphilis. Clin Lab 2013; 59: 523-529.
Marangoni A, Nardini P, Foschi C et al. Evaluation of the BioPlex 2200 syphilis system as a first-line method of reverse-sequence screening for syphilis diagnosis. Clin Vaccine Immunol 2013; 20: 1084-1088.
Castro A, Jost H, Cox D et al. A comparison of the analytical level of agreement of nine treponemal assays for syphilis and possible implications for screening algorithms. BMJ Open 2013; 3: e003347.
Seña AC, White B, Sparling PF. Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis 2010; 51: 700-708.
Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204: 1297-1304.
Centers for Disease Control and Prevention (CDC). Discordant results from reverse sequence syphilis screening-five laboratories, United States, 2006-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 133-137.
Park IU, Fakile YF, Chow JM et al. Performance of treponemal tests for the diagnosis of syphilis. Clin Infect Dis 2019; 68: 913-918.
Šmajs D, Strouhal M, Knauf S. Genetics of human and animal uncultivable treponemal pathogens. Infect Genet Evol 2018; 61: 92-107.
Gray RR, Mulligan CJ, Molin BJ et al. Molecular evolution of the tprC, D, I, K, G and J genes in the pathogenic genus Treponema. Mol Biol Evol 2006; 23: 2220-2233.
Centurion-Lara A, Giacani L, Godornes C et al. Fine analysis of genetic diversity of the tpr gene family among treponemal species, subspecies and strains. PLoS Negl Trop Dis 2013; 7: e2222.
Tsuboi M, Nishijima T, Aoki T et al. Usefulness of automated latex turbidimetric rapid plasma reagin test for diagnosis and evaluation of treatment response in syphilis in comparison with manual card test: a prospective cohort study. J Clin Microbiol 2018; 56: e01003-e1018.
Osbak K, Abdellati S, Tsoumanis A et al. Evaluation of an automated quantitative latex immunoturbidimetric non-treponemal assay for diagnosis and follow-up of syphilis: a prospective cohort study. J Med Microbiol 2017; 66: 1130-1139.
Malm K, Andersson S, Fredlund H et al. Analytic evaluation of nine serological assays for diagnosis of syphilis. J Eur Acad Dermatol Venereol 2015; 29: 2369-2376.
Herring AJ, Ballard RC, Pope V et al. A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera. Sex Transm Infect 2006; 82(Suppl 5): v7-12.
Gliddon HD, Peeling R, Kamb ML, Toskin I, Wi TE, Taylor MM. A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis. Sex Transm Infect 2017; 93(S4): S3-S15.
Owusu-Edusei K, Jr, Gift TL, Ballard RC. Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcome in sub-Saharan Africa. Sex Transm Dis 2011; 38: 997-1003.
Castro AR, Esfandiari J, Kumar S et al. Novel point-of-care test for simultaneous detection of nontreponemal and treponemal antibodies in patients with syphilis. J Clin Microbiol 2010; 48: 4615-4619.
Yin YP, Chen XS, Wei WH et al. A dual point-of-care test shows good performance in simultaneously detecting nontreponemal and treponemal antibodies in patients with syphilis: a multisite evaluation study in China. Clin Infect Dis 2013; 56: 659-665.
Causer L, Kaldor JM, Conway DP et al. An evaluation of a novel dual point-of care test for syphilis as a tool to distinguish active from past treated infection. Clin Infect Dis 2015; 61: 184-191.
Owusu-Edusei K, Jr, Koski KA, Ballard RC. The tale of two serologic tests to screen for syphilis - treponemal and non-treponemal: does the order matter? Sex Transm Dis 2011; 38: 448-456.
Owusu-Edusei K, Jr, Peterman TA, Ballard RC. Serologic testing for syphilis in the United States: a cost-effectiveness analysis of two screening algorithms. Sex Transm Dis 2011; 38: 1-7.
Stoner B. Current controversies in the management of adult syphilis. Clin Infect Dis 2007; 44(Suppl 3): S130-146.
Workowski KA, Bolan GA. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64: 34-51.
Peng J, Lu Y, Yu H et al. Analysis of 2 reverse syphilis testing algorithms in diagnosis of syphilis: a large-cohort prospective study. Clin Infect Dis 2018; 67: 947-953.
Tong ML, Lin LR, Liu LL et al. Analysis of 3 algorithms for syphilis serodiagnosis and implications for clinical management. Clin Infect Dis 2014; 58: 1116-1124.
Cantor AG, Pappas M, Daeges M, Nelson HD. Screening for syphilis. Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2016; 315: 2328-2337.
Berry GJ, Loeffelholz MJ. Use of treponemal screening assay strength of signal to avoid unnecessary confirmatory testing. Sex Transm Dis 2016; 43: 737-740.
Liu LL, Lin LR, Tong ML et al. Incidence and risk factors for the prozone phenomenon in serologic testing for syphilis in a large cohort. Clin Infect Dis 2014; 59: 384-389.
Wöhrl S, Geusau A. Neurosyphilis is unlikely in patients with late latent syphilis and a negative blood VDRL test. Acta Derm Venereol 2006; 86: 335-339.
Tuddenham S, Obeng C, Ghanem KG. Neurosyphilis and ophthalmic syphilis in persons with negative rapid plasma reagin and positive treponemal antibody test results. Sex Transm Dis 2015; 42: 347-349.
Geusau A, Kittler H, Hein U, Dangl-Erlach E, Stingl G, Tschachler E. Biological false-positive tests comprise a high proportion of Venereal Disease Research Laboratory reactions in an analysis of 300 000 sera. Int J STD AIDS 2005; 16: 722-726.
Hooshmand H, Escobar MR, Kopf SW. Neurosyphilis; a study of 241 patients. JAMA 1972; 219: 726-729.
Löwhagen GB, Andersson M, Blomstrand C, Roupe G. Central nervous system involvement in early syphilis. Part I. Intrathecal immunoglobulin production. Acta Derm Venereol 1983; 63: 409-417.
Wiesel J, Rose DN, Silver AL, Sacks HS, Bernstein RH. Lumbar puncture in asymptomatic late syphilis. Arch Intern Med 1985; 145: 465-468.
Lukehart SA, Hook EW, III, Bakerzander SA, Collier AC, Critchlow CW, Handsfield HH. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109: 855-862.
Davis AP, Stern J, Tantalo L et al. How well do neurologic symptoms identify individuals with neurosyphilis. Clin Infect Dis 2018; 66: 363-367.
Marra CM, Tantalo LC, Maxwell CL, Ho EL, Sahi SK, Jones T. The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis. Sex Transm Dis 2012; 39: 453-457.
Tuddenham S, Ghanem KG. Neurosyphilis: knowledge gaps and controversies. Sex Transm Dis 2018; 45: 147-151.
Marra CM, Maxwell CL, Smith SL et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189: 369-376.
Shi M, Peng RR, Gao Z et al. Risk profiles of neurosyphilis in HIV-negative patients with primary, secondary and latent syphilis: implications for clinical intervention. J Eur Acad Dermatol Venereol 2016; 30: 659-666.
Libois A, De Wit S, Poll B et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007; 34: 141-144.
Harding AS, Ghanem KG. The performance of cerebrospinal fluid treponemal-specific antibody tests in neurosyphilis: a systematic review. Sex Transm Dis 2012; 39: 291-297.
Tomkins A, Ahmad S, Cousins D, Thng CM, Vilar FJ, Higgins SP. Screening for asymptomatic neurosyphilis in HIV: an observational study. Sex Transm Infect 2018; 94: 337-339.
Ghanem KG. Management of adult syphilis: Key questions to inform the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases treatment guidelines. Clin Infect Dis 2015; 61: S819-836.
Dabis R, Radcliffe K. What is the role of a full physical examination in the management of asymptomatic patients with late syphilis. Int J STD AIDS 2012; 23: 901-902.
Mohr JA, Griffiths W, Jackson R et al. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976; 236: 2208-2209.
Rolfs RT, Joesoef MR, Hendershot EF et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307-314.
Dabis R, Radcliffe K. Is it useful to perform a chest X-ray in asymptomatic patients with late syphilis. Int J STD AIDS 2011; 22: 105-106.
Rolfs RT. Treatment of syphilis, 1993. Clin Infect Dis 1995; 20(Suppl 1): S23-38.
Dunlop EMC. Survival of treponemes after treatment, comments, clinical conclusions and recommendations. Genitourin Med 1985; 61: 293-301.
Löwhagen GB, Brorson J-E, Kaijser B. Penicillin concentrations in cerebrospinal fluid and serum after intramuscular, intravenous and oral administration to syphilitic patients. Acta Derm Venereol 1983; 63: 53-57.
Goh BT, Smith GW, Samarasinghe L, Singh V, Lim KS. Penicillin concentrations in serum and cerebrospinal fluid after intramuscular injection of aqueous procaine penicillin 0.6 MU with and without oral probenecid. Br J Venereol Dis 1984; 60: 371-373.
Schoth PEM, Wolters EC. Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilis. Neurology 1987; 37: 1214-1216.
Faber WR, Bos JD, Tietra PJGM, Fass H, van Ejk RTW. Treponemicidal level of amoxycillin in cerebrospinal fluid after oral administration. Sex Transm Dis 1983; 10: 148-150.
Tanizaki R, Nishijima T, Aoki T et al. High-dose oral amoxicillin plus probenecid is highly effective for syphilis in patients with HIV infection. Clin Infect Dis 2015; 61: 177-183.
Ghanem KG, Erbelding EJ, Cheng WW, Rompalo AM. Doxycycline compared with benzathine penicillin for the treatment of syphilis. Clin Infect Dis 2006; 42: e45-49.
Antonio MB, Cuba GT, Vasconcelos RP et al. Natural experiment of syphilis treatment with doxycycline or benzathine penicillin in HIV-infected patients. AIDS 2019; 33: 77-81.
Salado-Rasmussen K, Hoffmann S, Cowan S et al. Serological response to treatment of syphilis with doxycycline compared with penicillin in HIV-infected individuals. Acta Derm Venereol 2016; 96: 807-811.
Tsai JC, Lin HY, Lu PL et al. Comparison of serological response to doxycycline versus benzathine-penicillin G in the treatment of early syphilis in HIV-infected patients: a multicentre observational study. PLoS One 2014; 9: e109813.
Liu H-Y, Han Y, Chen X-S et al. Comparison of efficacy of treatments for early syphilis: a systematic review and network meta-analysis of randomized controlled trials and observational studies. PLoS One 2017; 12: e0180001.
Marra CM, Boutin P, McArthur JC et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000; 30: 540-544.
Dowell ME, Ross PG, Musher DM, Cate TR, Baughn RE. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992; 93: 481-488.
Cao Y, Su X, Wang Q et al. A multicentre study evaluating ceftriaxone and benzathine penicillin G as treatment agents for early syphilis in Jiangsu. China. Clin Infect Dis 2017; 65: 1683-1688.
Smith NH, Musher DM, Huang DB et al. Response of HIV infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004; 15: 328-332.
Riedner G, Rusizoka M, Todd J et al. Single dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005; 353: 1236-1244.
Hook EW, Behets F, Van Damme K et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis 2010; 201: 1729-1735.
Lukehart SA, Godornes C, Molini BJ et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004; 351: 154-158.
Stamm LV. Global challenge of antibiotic-resistant Treponema pallidum. Antimicrob Agents Chemother 2010; 54: 583-589.
Zhou P, Li K, Lu H et al. Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai. Sex Transm Dis 2010; 37: 726-729.
Chen XS, Yin YP, Wei WH et al. High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China. Clin Microbiol Infect 2013; 19: 975-979.
Gjestland T. The Oslo study of untreated syphilis; an epidemiologic investigation of the natural course of the syphilitic infection based upon a re-study of the Boeck-Bruusgaard material. Acta Derm Venereol Suppl (Stockh) 1955; 35(Suppl 34):3-368; Annex I-LVI.
Amir J, Ginat S, Cohen YH, Marcus TE, Keller N, Varsano I. Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis 1998; 17: 890-893.
Crowe G, Theodore C, Forster GE, Goh BT. Acceptability and compliance with daily injections of procaine penicillin in the treatment of syphilis-treponemal infection. Sex Transm Dis 1997; 24: 127-130.
Wong T, Singh AE, De P. Primary syphilis treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med 2008; 121: 903-908.
Janier M, Libar E, Bonnet A et al. Treatment of late syphilis with 2.4 million units benzathine penicillin G (BPG): tolerance of single versus divided doses. Sex Transm Dis 2012; 39: 359-360.
Nurse-Findlay S, Taylor MM, Savage M et al. Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: an evaluation from multi-country surveys and stakeholder interviews. PLoS Med. 2017; 14: e1002473.
Boot JM, Oranje AP, De Groot R, Tan G, Stolz E. Congenital syphilis. Int J STD AIDS 1992; 3: 161-167.
Kamb ML, Newman LM, Riley PL, Mark J, Hawkes SJ, Malik T et al. A road map for the global elimination of congenital syphilis. Obstet Gynecol Int 2010; 2010: 312798. https://doi.org/10.1155/2010/312798.
Hong FC, Wu XB, Yang F et al. Risk of congenital syphilis (CS) following treatment of maternal syphilis: results of a CS control program in China. Clin Infect Dis 2017; 65: 588-594.
Peterman TA, Newman DR, Davis D, Su JR. Do women with persistently negative nontreponemal test results transmit syphilis during pregnancy? Sex Transm Dis 2013; 40: 311-315.
Walker GJA. Antibiotics for syphilis diagnosed during pregnancy. Cochrane Database Syst Rev 2001; 3: CD001143. https://doi.org/10.1002/14651858.CD001143.
Herremans T, Kortbeek L, Notermans DW. A review of diagnostic tests for congenital syphilis in newborns. Eur J Clin Microbiol Infect Dis 2010; 29: 495-501.
Blank LJ, Rompalo AM, Erbelding EJ, Zenilman JM, Ghanem KG. Treatment of syphilis in HIV-infected subjects: a systematic review of the literature. Sex Transm Infect 2011; 87: 9-16.
Janier M, Chastang C, Spindler E et al. A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis. Dermatology 1999; 198: 362-369.
Seña AC, Wolff M, Martin DH et al. Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis 2011; 53: 1092-1099.
Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted disease clinics. Sex Transm Infect 2007; 83: 97-101.
Fröhlich-Knaute D, Graf N, Lautenschlager S, Weber R, Bosshard PP. Serological response to treatment of syphilis according to disease stage and HIV status. Clin Infect Dis 2012; 55: 1615-1622.
Gonzalez-Lopez JJ, Fernandez-Guerrero ML, Lujan R, Fernandez-Tostado S, de Gorgolas M, Requena L. Factors determining serologic response to treatment in patients with syphilis. Clin Infect Dis 2009; 49: 1505-1511.
Courjon J, Hubiche T, Dupin N, Grange PA, Del Giudice P. Clinical aspects of syphilis reinfection in HIV-infected patients. Dermatology 2015; 230: 302-307.
Ganesan A, Mesner O, Okulicz JF et al. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653-660.
Costa-Silva M, Azevedo C, Azevedo F, Lisboa C. Early syphilis treatment in HIV-infected patients: single dose vs. three doses of benzathine penicillin G. J Eur Acad Dermatol Venereol 2016; 10: 1805-1809.
Cortes NJ, Afzali B, MacLean D et al. Transmission of syphilis by solid organ transplantation. Am J Transplant 2006; 6: 2497-2499.
Arando M, Fernandez-Naval C, Mota-Foix M et al. The Jarisch-Herxheimer reaction in syphilis: could molecular typing help to understand it better? J Eur Acad Dermatol Venereol 2018; 32: 1791-1795.
Degos R, Lortat-Jacob E, Macrez P. Aorto-myocardite syphilitique séro-positive. Bull Soc Fr Dermatol Syphil 1970; 77: 32-33.
Belum GR, Belum VR, Arudra SKC et al. The Jarisch-Herxheimer reaction: revisited. Travel Med Infect Dis 2013; 11: 231-237.
Gudjonsson H, Skog E. The effect of prednisolone on the Jarisch-Herxheimer reaction. Acta Dermatol Venereol 1968; 48: 15-18.
Beymer M, DeVost MA, Weiss RE et al. Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California. Sex Transm Infect 2018; 94: 457-462.
Traeger MW, Schroeder SE, Wright EJ et al. Effects of pre-exposure prophylaxis for the prevention of Human Immunodeficiency Virus infection on sexual risk behaviour in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis 2018; 67: 676-686.
Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner JD. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex Transm Dis 2015; 42: 98-103.
Molina JM, Charreau I, Chidiac C et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis 2018; 18: 308-317.
Grant JS, Stafylis C, Celum C et al. Doxycycline prophylaxis for bacterial sexually transmitted infections. Clin Infect Dis 2020; 70: 1247-1253.
Tiplica GS, Radcliffe K, Evans C et al. European Guidelines for the management of partners of persons with sexually transmitted infections. J Eur Acad Dermatol Venereol 2015; 29: 1251-1257.
Schober PC, Gabriel G, White P, Felton WF, Thin RN. How infectious is syphilis? Br J Vener Dis 1983; 59: 217-219.
Katz KA, Lee MA, Gray T, Marcus JL, Pierce EF. Repeat syphilis among men who have sex with men-San Diego county, 2004-2009. Sex Transm Dis 2011; 38: 349-352.
Seña AC, Zang X-H, Li T et al. A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapy. BMC Infect Dis 2015; 15: 479. https://doi.org/10.1186/s12879-015-1209-0.
Seña AC, Wolff M, Behets F et al. Rate of decline in Nontreponemal antibody titers and seroreversion after treatment of early syphilis. Sex Transm Dis 2017; 44: 6-10.
Pastuszczak M, Jakiela B, Wojas-Pelc A. Association of interleukin-10 promoter polymorphisms with serofast state after syphilis treatment. Sex Transm Infect 2019; 95: 163-168.
Knaute DF, Graf N, Lautenschlager S, Weber R, Bosshard PP. Serological response to treatment of syphilis according to disease stage and HIV status. Clin Infect Dis 2012; 55: 1615-1622.
Kenyon C, Tsoumanis A, Osbak K et al. Repeat syphilis has a different immune response compared with initial syphilis: an analysis of biomarker kinetics in two cohorts. Sex Transm Infect 2018; 94: 180-186.
Marra CM, Maxwell CL, Tantalo L et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter. Clin Infect Dis 2004; 38: 1001-1006.
Marra CM, Maxwell CL, Tantalo SC, Sahi SK, Lukehart SA. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008; 47: 893-899.